TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Bionomit Public AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
13
|
61
|
1 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-95
|
0
|
-3,295 |
| EBITDA |
-95
|
0
|
-52 |
| Total assets |
4,913
|
4,963
|
4,942 |
| Current assets |
90
|
96
|
48 |
| Current liabilities |
146
|
101
|
98 |
| Equity capital |
4,730
|
4,825
|
4,797 |
| - share capital |
500
|
500
|
500 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
96.3%
|
97.2%
|
97.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-730.8%
|
0%
|
-329500% |
| Return on assets (ROA) |
-1.9%
|
0%
|
-66.7% |
| Current ratio |
61.6%
|
95.0%
|
49.0% |
| Return on equity (ROE) |
-2.0%
|
0%
|
-68.7% |
| Change turnover |
-48
|
60
|
-1 |
| Change turnover % |
-79%
|
6000%
|
-50% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.